Navigation Links
Cardium Reports on Second Quarter 2008 Highlights and Financial Results
Date:8/11/2008

involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. For example, there can be no assurance that human clinical trials can be conducted and completed in an efficient and successful manner, that product modifications or launches will be successful or that the resulting products will be favorably received in the marketplace, that results or trends observed in one clinical study or procedure will be reproduced in subsequent studies or procedures, that our products or product candidates will prove to be sufficiently safe and effective, that necessary regulatory approvals will be obtained, that third parties on whom we depend will perform as anticipated, or that our products or product candidates will not be unfavorably compared to competitive products that may be regarded as safer, more effective, easier to use or less expensive. Actual results may also differ substantially from those described in or contemplated by this press release due to risks and uncertainties that exist in our operations and business environment, including, without limitation, risks and uncertainties that are inherent in the development of complex biologics and therapeutic hypothermia devices and in the conduct of human clinical trials, including the timing, costs and outcomes of such trials, our ability to obtain necessary funding, regulatory approvals and expected qualifications, our ability to successfully accelerate the commercialization of our therapeutic hypothermia devices and launch new devices within the timeframes contemplated, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities and Exchange Commission. We undertake no obligation to release pu
'/>"/>
SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
2. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
3. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
4. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
5. Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
6. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
7. Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
8. CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE
9. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
10. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
11. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium ... technology market intelligence, the United States ... (TEO) device markets will expand moderately through 2022, ... segments. In particular, increasing interest in drug-eluting beads ...
(Date:1/15/2014)... LAVAL, Quebec , Jan. 15, 2014  Valeant Pharmaceuticals ... VRX) announced that the applicable waiting period under the ... to the previously announced tender offer by its indirect ... the outstanding shares of common stock of Solta Medical, ...
(Date:1/15/2014)... 15, 2014  Zafgen, Inc., a leading biopharmaceutical company ... obese patients, today announced initial results from its ... of methionine aminopeptidase 2 (MetAP2), in patients with ... obesity.  These results showed improvements in body weight, ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... NEW YORK, March 16, 2011 Reportlinker.com announces ... in its catalogue: Global ... http://www.reportlinker.com/p098415/Global-Cell/Tissue-Culture-Supplies-Industry.html This report analyzes ... US$ Million by the following Product Segments: Media, ...
... NEW YORK, March 16, 2011 Reportlinker.com announces ... in its catalogue: Global Temperature ... This report analyzes the worldwide ... by the following Product Segments: Digital Thermometers, Infrared ...
Cached Medicine Technology:Global Cell/Tissue Culture Supplies Industry 2Global Cell/Tissue Culture Supplies Industry 3Global Cell/Tissue Culture Supplies Industry 4Global Cell/Tissue Culture Supplies Industry 5Global Cell/Tissue Culture Supplies Industry 6Global Cell/Tissue Culture Supplies Industry 7Global Cell/Tissue Culture Supplies Industry 8Global Cell/Tissue Culture Supplies Industry 9Global Cell/Tissue Culture Supplies Industry 10Global Cell/Tissue Culture Supplies Industry 11Global Cell/Tissue Culture Supplies Industry 12Global Cell/Tissue Culture Supplies Industry 13Global Cell/Tissue Culture Supplies Industry 14Global Cell/Tissue Culture Supplies Industry 15Global Cell/Tissue Culture Supplies Industry 16Global Cell/Tissue Culture Supplies Industry 17Global Cell/Tissue Culture Supplies Industry 18Global Cell/Tissue Culture Supplies Industry 19Global Temperature Monitoring Devices Industry 2Global Temperature Monitoring Devices Industry 3Global Temperature Monitoring Devices Industry 4Global Temperature Monitoring Devices Industry 5Global Temperature Monitoring Devices Industry 6Global Temperature Monitoring Devices Industry 7Global Temperature Monitoring Devices Industry 8Global Temperature Monitoring Devices Industry 9Global Temperature Monitoring Devices Industry 10Global Temperature Monitoring Devices Industry 11Global Temperature Monitoring Devices Industry 12Global Temperature Monitoring Devices Industry 13Global Temperature Monitoring Devices Industry 14Global Temperature Monitoring Devices Industry 15Global Temperature Monitoring Devices Industry 16Global Temperature Monitoring Devices Industry 17Global Temperature Monitoring Devices Industry 18
(Date:4/24/2014)... than one out of three survivors of critical ... The Lancet Respiratory Medicine , and the ... than mentally. , It is one of the ... functional outcomes of critical care survivors, according to ... Medicine, and it highlights a significant public health ...
(Date:4/24/2014)... researcher has found a relationship between motor skill deficiencies ... disorder in very young children. , The findings, ... direct relationship between motor skills and autism severity, indicate ... be included in treatment plans for young children with ... College of Public Health and Human Sciences. , ...
(Date:4/23/2014)... investigators may lead to greater availability and acceptability of ... use of fecal material from healthy donors to treat ... ( C. difficile ) bacteria. In their paper ... Diseases , the researchers report that use of prescreened ... as successful in curing recurrent C. difficile ...
(Date:4/23/2014)... Washington State University Spokane have developed a new ... nod off behind the wheel. , Their recently ... are more variable in drowsy driversand offers an ... video-based driver drowsiness detection systems. , Van Dongen"Video-based ... car is drifting out of its lane are ...
(Date:4/23/2014)... report that rats exposed to high-energy particles, simulating conditions ... show lapses in attention and slower reaction times, even ... ranges. , The cognitive impairments which affected a ... appear to be linked to protein changes in ... to hold true in humans, suggest it may be ...
Breaking Medicine News(10 mins):Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 2Health News:Vanderbilt study finds physical signs of depression common among ICU survivors 3Health News:Motor skill deficiencies linked to autism severity in new research 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 3Health News:WSU innovation improves drowsy driver detection 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 2Health News:Some astronauts at risk for cognitive impairment, animal studies suggest 3
... eating beef from cattle with mad cow disease may ... individuals, say researchers according to a recent study. ... variant form of Creutzfeldt-Jakob disease (vCJD), which has been ... bovine spongiform encephalopathy (BSE), can be transmitted through an ...
... of aspirin may reduce the risk of colon polyps, which ... women between 34 and 77 years old. The participants underwent ... years, nearly 1,400 of the women were diagnosed with adenoma, ... ,Results show participants who reported taking aspirin regularly were 25-percent ...
... there is a lot of confusion about what type of diet ... a low carbohydrate diet, a new study shows a low fat, ... the amount of food is not restricted. ,For the research, ... alone and in combination with exercise. They looked at body weight ...
... blood may predict the risk of heart attack or death ... new study. ,Researchers conducted a study to determine whether ... for death or non-fatal heart attack in patients with acute ... factor family and it acts as an instigator of hardening ...
... Periodontal disease is a chronic bacterial infection that affects ... research shows a blood test can not only reveal ... periodontal disease risk. ,Researchers from Japan studied ... blood tests that checked for 37 items, including cholesterol ...
... and one that causes excessive absence from work. Many doctors ... returning them to normal activity levels. But many people with ... ,A new study suggests people with low back pain ... was conducted among the employees of an airline company in ...
Cached Medicine News:
... The Bugbox-M incorporates all the familiar and proven ... interface with the Ruskinn gas mixing system.The gas ... - 20% in 0.1% increments), carbon dioxide (0% ... - 10% in 1% increments) components of the ...
The airlock allows anaerobic entry of large flasks, vessels, and up to 90 plates at a time....
The 500 plate capacity MG-500 has an airlock for ease of use and an additional 100 plate capacity. Refrigeration is also available for growth of psychrophilic organisms...
... the operating theatre is ready for all current ... Its modern design allows a quick, problem-free conversion ... components are connected securely and sturdily to MARS ... if there should ever be a problem in ...
Medicine Products: